Detail akcie Purple Btch Sp ADR online

Business Summary: Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Purple Biotech Ltd - ADR revenues was not reported. Net loss decreased 58% to $2.8M. Lower net loss reflects Research and development expenses decrease of 73% to $1.9M (expense), General and administrative expenses decrease of 22% to $2.1M (expense), Finance expense decrease of 93% to $40K (expense).